You don’t have to try the “3D avatar model†for you.
For cancer patients, how to find a tumor chemotherapy solution that is effective for them is crucial. Is there any way to detect whether a drug is suitable for a patient before chemotherapy? Even taking the patient's "replacement" first test? According to Dr. Fang Changge, a researcher at the Newborn Vascular Center Laboratory of the National Institute of Cancer Research, and Dr. Fang Changge from APD Medical Technology Co., Ltd., the answer is yes. Recently, sponsored by the National Tumor Minimally Invasive Therapeutic Industry Technology Innovation Strategic Alliance, the “Institute of Clinical Application of Sino-US Cancer Precision Treatment Frontier Technology and the Inaugural Meeting of the Interventional Specialist Branch of the Beijing Medical Association†organized by Ping Pude Medical Technology Co., Ltd. On the other hand, the “3D avatar model†drug technology that she invented by Fang Changge attracted widespread attention. Fang Changge introduced, in a nutshell, the "3D avatar model" is a needle biopsy from the patient, taking a 1.5 cm long, 1 mm wide tumor tissue, and then dividing it into more than 300 small pieces, put it into one By culturing in a container, it is possible to simulate the process of "reproducing" the development of tumor tissue in the human body. The key to the effectiveness of the model is that the tissue taken by the acupuncture biopsy is “small and complete,†which carries the “all biosignatures†of the cancerous foci on the host, covering blood vessels, blood cells, cancer cells, and cells. Important information such as matrix and immune cells can simulate host cancer to some extent. "The transition from 2D to 3D will bring about major changes in cancer treatment, and it will provide greater protection for patients with accurate individualized medication." Fang Changge explained that the 3D model can maintain the signal pathway, gene and protein expression profile of the cells, which can be used as a “drug test substitute†for patients, providing rapid personalized drug testing, and helping clinicians suppress cancer against drugs. The effects of deterioration and metastasis were assessed. Finally, the clinician is provided with a list of drug sensitivities to assist them in selecting drugs for patients. “Because in vitro, the in vitro replacement is not completely the same as the human body. Therefore, drugs that are very effective in in vitro testing do not necessarily achieve good results in the clinic, but the detection of ineffective drugs is almost ineffective in clinical practice. Clinical research has been well proven." Fang Changge said. Biotechnology,Tebuthiuron,Trifloxystrobin,Flufenacet,Amicarbazone,Prothioconazole,Sulfentrazone Changzhou Satidi Import and Export Co., Ltd. , https://www.guanjiejts.com